MJFF Publications

3141 - 3150 of 6422 Results

Title

Year

Year
2020
2022
2022
2022
2022
2022
2022
2022
2022
2022

GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning
2020

Summary Details

OPEN

Title: GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning

Author(s): Özlem Muslu, Charles Tapley Hoyt, Mauricio Lacerda, Martin Hofmann‐Apitius, Holger Fröhlich

Journal Name: IEEE/ACM Transactions on Computational Biology and Bioinformatics

Publisher: Institute of Electrical and Electronics Engineers (IEEE)

Vol: 19

Issue #: 1

Start Page: 491

End Page: 500

Publication Date: 2020-06-19

Open Access(OA) Status: OPEN

License: cc-by

DOI - Digital Object Identifier: 10.1109/tcbb.2020.3003830

Best OA location URL: https://ieeexplore.ieee.org/ielx7/8857/9702518/09121705.pdf

Citation Count: 8
ECTRIMS 2022 – Poster
2022

Summary Details

OPEN

Title: ECTRIMS 2022 – Poster

Author(s): Farah Haddad, Samuel Boudet, Laurent Peyrodie, Nicolas Vandenbroucke, Julien Poupart, Patrick Hautecœur, Vincent Chieux, G Forzy

Journal Name: Multiple Sclerosis Journal

Publisher: SAGE Publications

Vol: 28

Issue #: 3_suppl

Start Page: 130

End Page: 691

Publication Date: 2022-10-01

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1177/13524585221123687

Best OA location URL: https://lirias.kuleuven.be/bitstream/20.500.12942/704893/2/poster_ECTRIMS_RIMS_Oct%202022_Peeters.pdf

Citation Count: 20
Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls
2022

Summary Details

OPEN

Title: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls

Author(s): Tyler L. Borko, Britney Barrera, Christopher Mizenko, Aurélie Ledreux, Ryan Kammeyer, Alanna Ritchie, Sean Selva, Stefan Sillau, Eric Engebretson, Rebecca Seale, Brooke Valdez, Jeffrey L. Bennett, Timothy R. Vollmer, Kavita Nair, Amanda L. Piquet

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1d

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdf

Citation Count: 0
A Severe Case of Lupus Cerebritis
2022

Summary Details

OPEN

Title: A Severe Case of Lupus Cerebritis

Author(s): Christopher Szewczyk, Hemil Gonzalez

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8a

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdf

Citation Count: 1
Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences
2022

Summary Details

OPEN

Title: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences

Author(s): Luo Guo, Yann Le Guen, Adityasai Ambati, Selina Yogeshwar, Vicente Peris-Sempere, Jean‐Charles Lambert, Michael D. Greicius, Emmanuel Mignot, AD PD Collaborators

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2d

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdf

Citation Count: 1
The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
2022

Summary Details

OPEN

Title: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis

Author(s): Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, J. Singleton, Dana Mitchell, Janel Fedler, Dixie Ecklund, David Klements, Michele Costigan, Stacey Clardy

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdf

Citation Count: 3
Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
2022

Summary Details

OPEN

Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)

Author(s): Jeffrey Allen, Eduardo Nobile-Orazio, Stojan Perić, Hans Katzberg, Stephanie Cadour, Inge Van de Walle, Iris Van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W Ludo van der Pol

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf

Citation Count: 3
An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
2022

Summary Details

OPEN

Title: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies

Author(s): Tyler L. Borko, Sean Selva, Ryan D. Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau, Daniel M. Pastula, Maite Sabalza, Iswariya Venkataraman, Eagappanath Thiruppathi, Jeffrey L. Bennett, Enrique Alarcón Álvarez, Robert A. Gross, Anna Shah, Ryan Kammeyer, Timothy R. Vollmer, Ross M. Kedl, John R. Corboy, Elena W.Y. Hsieh, Amanda L. Piquet

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 23_Supplement_2

Start Page:

End Page:

Publication Date: 2022-12-05

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0a

Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdf

Citation Count: 1
Quality of Life for Patients With Parkinson Disease
2022

Summary Details

OPEN

Title: Quality of Life for Patients With Parkinson Disease

Author(s): Lauren Talman

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 98

Issue #: 22

Start Page:

End Page:

Publication Date: 2022-05-30

Open Access(OA) Status: OPEN

License:

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741

Citation Count: 3
What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
2022

Summary Details

OPEN

Title: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?

Author(s): John Seibyl, Phillip H. Kuo

Journal Name: Neurology

Publisher: Ovid Technologies (Wolters Kluwer Health)

Vol: 99

Issue #: 7_Supplement_1

Start Page: 61

End Page: 67

Publication Date: 2022-08-15

Open Access(OA) Status: OPEN

License: cc-by-nc-nd

DOI - Digital Object Identifier: 10.1212/wnl.0000000000200786

Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdf

Citation Count: 18

Results Per Page

Animations

MJFF Publications